Comments on: Addition of Elotuzumab to Bortezomib/Dexamethasone Improves Survival in Relapsed/Refractory Multiple Myeloma https://www.oncologynurseadvisor.com/home/cancer-types/multiple-myeloma/addition-of-elotuzumab-to-bortezomib-dexamethasone-improves-survival-in-relapsed-refractory-multiple-myeloma/ Sat, 05 Jan 2019 00:14:12 +0000 hourly 1 https://wordpress.org/?v=6.4.3